Bispecific Antibodies Survey

We are embarking on a national project to help implement bispecific antibodies as a treatment for multiple myeloma accessed through clinical trials, named patient schemes or routine care if NICE approvals are positive. To do this we would like to understand the challenges you may face with these treatments both with your hospital but also for patients. We are keen to hear from all centres irrespective of your current experience with these agents and particularly those from level 1 and level 2 centres as well as the tertiary centres.

Your feedback will enable us to shape this national work and we would be grateful if you would complete this on-line survey to help us tailor the project to your needs. It should take no more than 10 minutes.

https://qualtrics.ucl.ac.uk/jfe/form/SV_578UhAh5h7JiA2G

The survey will be open until March 14th.

To obtain more information about this work please contact Dr. Pinkie Chambers ([email protected])